SpliSense secures $28.5 million in funding to advance mRNA-altering pipeline for treatment of CF
13.05.21 | Meir Orbach
This site uses cookies to ensure the best viewing experience for our readers.
Biopharma
5 stories about Biopharma
Israeli biopharma startup Omnix Medical awarded €10.8 million from EU to fight drug-resistant bacteria
26.01.21 | Meir Orbach
Nasdaq-Listed Biopharma Company Chiasma Raises $34.5 Million in Public Offering
09.04.19 | CTech
Gastro Treatment Company RedHill Wants to Raise $117 on Nasdaq
24.07.18 | Lilach Baumer
RedHill's Public Offering Spooks Investors, Sends Stock Down
09.11.17 | Dror Reich
Tag does not exist. Please try again.